CARGO Therapeutics, Inc. (CRGX)
NASDAQ: CRGX · Real-Time Price · USD
3.600
+0.210 (6.19%)
At close: Jan 31, 2025, 4:00 PM
3.550
-0.050 (-1.39%)
After-hours: Jan 31, 2025, 7:54 PM EST
CARGO Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for CARGO Therapeutics stock have an average target of 4.67, with a low estimate of 3.00 and a high estimate of 7.00. The average target predicts an increase of 29.72% from the current stock price of 3.60.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for CRGX stock from 7 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 0 |
| Buy | 3 | 3 | 3 | 4 | 4 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 6 |
| Sell | 0 | 0 | 0 | 0 | 0 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 8 | 8 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Strong Buy → Hold Downgrades $32 → $7 | Strong Buy → Hold | Downgrades | $32 → $7 | +94.44% | Jan 30, 2025 |
| Piper Sandler | Piper Sandler | Buy → Hold Downgrades $34 → $4 | Buy → Hold | Downgrades | $34 → $4 | +11.11% | Jan 30, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jan 30, 2025 |
| JP Morgan | JP Morgan | Buy → Sell Downgrades n/a | Buy → Sell | Downgrades | n/a | n/a | Jan 30, 2025 |
| William Blair | William Blair | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jan 30, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
728.58K
EPS This Year
-3.85
from -16.53
EPS Next Year
-4.19
from -3.85
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | n/a | 5.3M | 192.7M | |||
| Avg | n/a | 728,576 | 43.5M | |||
| Low | n/a | n/a | 6.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | 26,347.5% | |||
| Avg | - | - | 5,870.1% | |||
| Low | - | - | 841.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -3.74 | -3.31 | -2.50 | |||
| Avg | -3.85 | -4.19 | -4.05 | |||
| Low | -4.07 | -4.76 | -4.95 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.